Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.550
-0.150 (-4.05%)
At close: Sep 18, 2026, 4:00 PM EDT
3.620
+0.070 (1.97%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $209.79 million as of September 18, 2026. Its market cap has increased by 79.46% in one year.
Market Cap
209.79M
Enterprise Value
50.69M
1-Year Change
79.46%
Ranking
Category
Stock Price
$3.55
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $209.79M, an increase of 21.15%. That is a compound annual growth rate of 2.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 209.79M | -26.55% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 218.76M |
| Eledon Pharmaceuticals | 217.18M |
| Protalix BioTherapeutics | 215.93M |
| Alector | 214.94M |
| Veraxa Biotech AG | 213.53M |
| Keros Therapeutics | 212.94M |
| Adagene | 212.84M |
| Sol-Gel Technologies | 207.70M |